A molecular classification of human mesenchymal stromal cells
Open Access
Abstract
Mesenchymal stromal cells (MSC) are widely used for the study of mesenchymal tissue repair, and increasingly adopted for cell therapy, despite the lack of consensus on the identity of these cells. In part this is due to the lack of specificity of MSC markers. Distinguishing MSC from other stromal cells such as fibroblasts is particularly difficult using standard analysis of surface proteins, and there is an urgent need for improved classification approaches. Transcriptome profiling is commonly used to describe and compare different cell types; however, efforts to identify specific markers of rare cellular subsets may be confounded by the small sample sizes of most studies. Consequently, it is difficult to derive reproducible, and therefore useful markers. We addressed the question of MSC classification with a large integrative analysis of many public MSC datasets. We derived a sparse classifier (The Rohart MSC test) that accurately distinguished MSC from non-MSC samples with >97% accuracy on an internal training set of 635 samples from 41 studies derived on 10 different microarray platforms. The classifier was validated on an external test set of 1,291 samples from 65 studies derived on 15 different platforms, with >95% accuracy. The genes that contribute to the MSC classifier formed a protein-interaction network that included known MSC markers. Further evidence of the relevance of this new MSC panel came from the high number of Mendelian disorders associated with mutations in more than 65% of the network. These result in mesenchymal defects, particularly impacting on skeletal growth and function. The Rohart MSC test is a simplein silicotest that accurately discriminates MSC from fibroblasts, other adult stem/progenitor cell types or differentiated stromal cells. It has been implemented in thewww.stemformatics.orgresource, to assist researchers wishing to benchmark their own MSC datasets or data from the public domain. The code is available from the CRAN repository and all data used to generate the MSC test is available to download via the Gene Expression Omnibus or the Stemformatics resource.Keywords
All Related Versions
Funding Information
- Australian Research Council (SR1101002)
- ARC Discovery Project (DP130100777)
- JEM Research Foundation
- National Health and Medical Research Council (APP1023368)
- NHMRC Career Development Fellowship (1023371)
- National Heart Foundation of Australia
- Australian Cancer Research Foundation (ACRF)
This publication has 61 references indexed in Scilit:
- The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasisNature Cell Biology, 2013
- Human Dermis Harbors Distinct Mesenchymal Stromal Cell SubsetsJournal of Investigative Dermatology, 2012
- BioMart: a data federation framework for large collaborative projectsDatabase: The Journal of Biological Databases and Curation, 2011
- ArrayExpress update--an archive of microarray and high-throughput sequencing-based functional genomics experimentsNucleic Acids Research, 2010
- A framework for oligonucleotide microarray preprocessingBioinformatics, 2010
- Trafficking defects and loss of ligand binding are the underlying causes of all reported DDR2 missense mutations found in SMED-SL patientsHuman Molecular Genetics, 2010
- Bidirectional Modulation of Adipogenesis by the Secreted Protein Ccdc80/DRO1/URBJournal of Biological Chemistry, 2009
- A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human OrgansCell Stem Cell, 2008
- lumi: a pipeline for processing Illumina microarrayBioinformatics, 2008
- Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statementCytotherapy, 2006